Selective serotonin reuptake inhibitor (Simple English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Selective serotonin reuptake inhibitor" in Simple English language version.

refsWebsite

Global rank Simple English rank

34nih.gov

4^th place

6^th place

30doi.org

2^nd place

3^rd place

14semanticscholar.org

11^th place

9^th place

7archive.org

6^th place

4^th place

4fda.gov

447^th place

1,594^th place

3web.archive.org

1^st place

2nice.org.uk

3,258^th place

low place

2worldcat.org

5^th place

1medscape.com

719^th place

817^th place

1guidelines.gov

low place

1handle.net

102^nd place

229^th place

1gov.uk

432^nd place

309^th place

1nationalarchives.gov.uk

744^th place

308^th place

1mhra.gov.uk

low place

1emedicinehealth.com

8,799^th place

6,741^st place

1psychiatryonline.org

4,032^nd place

1,910^th place

1ucsd.edu

1,933^rd place

1,317^th place

archive.org

Preskorn, Sheldon H.; Ross, Ruth; Stanga, Christine Y. (2004). "Selective Serotonin Reuptake Inhibitors". In Sheldon H. Preskorn; Hohn P. Feighner; Christina Y. Stanga; Ruth Ross (eds.). Antidepressants: Past, Present and Future. Berlin: Springer. pp. 241–62. ISBN 978-3-540-43054-4.
Kennedy SH; Rizvi S (2009). "Sexual Dysfunction, Depression, and the Impact of Antidepressants". Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977. S2CID 739831.
Taylor, D; Carol, P; Shitij, K (2012). The Maudsley Prescribing Guidelines in Psychiatry. West Sussex: Wiley-Blackwell. ISBN 9780470979693.
Andrade C; Sandarsh S (2010). "Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–1575. doi:10.4088/JCP.09r05786blu. PMID 21190637.
Andrade C; Sandarsh S (2010). "Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–75. doi:10.4088/JCP.09r05786blu. PMID 21190637.
Leo RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". The Journal of Clinical Psychiatry. 57 (10): 449–54. doi:10.4088/JCP.v57n1002. PMID 8909330.
Borys DJ; Setzer SC (1992). "Acute fluoxetine overdose: a report of 234 cases". The American Journal of Emergency Medicine. 10 (2): 115–20. doi:10.1016/0735-6757(92)90041-U. PMID 1586402.

doi.org

Kapczinski F; Lima MS (2003). Kapczinski, Flavio FK (ed.). "Antidepressants for generalized anxiety disorder". The Cochrane Database of Systematic Reviews (2): CD003592. doi:10.1002/14651858.CD003592. PMID 12804478.
Arroll B; Elley CR (2009). Arroll, Bruce (ed.). "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews. 2014 (3): CD007954. doi:10.1002/14651858.CD007954. PMC 10576545. PMID 19588448.
Hetrick SE; Purcell R (July 7, 2010). "Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)". The Cochrane Database of Systematic Reviews (7): CD007316. doi:10.1002/14651858.CD007316.pub2. PMID 20614457.
Berger W; Mendlowicz MV (2009). "Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33 (2): 169–180. doi:10.1016/j.pnpbp.2008.12.004. ISSN 0278-5846. PMC 2720612. PMID 19141307.
Bandelow B; Zohar J (2008). "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision". The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry. 9 (4): 248–312. doi:10.1080/15622970802465807. ISSN 1562-2975. PMID 18949648. S2CID 39027026.
Hoskins M; Pearce J (2015). "Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis". British Journal of Psychiatry. 206 (2): 93–100. doi:10.1192/bjp.bp.114.148551. PMID 25644881.
Flament MF; Bissada H (2012). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249. S2CID 24864203.
Sansone RA; Sansone LA 2008 (2008). "Pain, Pain, Go Away: Antidepressants and Pain Management". Psychiatry. 5 (12): 16–19. doi:10.4230/LIPIcs.FSTTCS.2015.69. PMC 2729622. PMID 19724772. S2CID 2729622.{{cite journal}}: CS1 maint: numeric names: authors list (link) CS1 maint: unflagged free DOI (link)
Artigas F (2013). "Serotonin Receptors Involved in Antidepressant Effects". Pharmacology and Therapeutics. 137 (1). Elsevier: 119–131. doi:10.1016/j.pharmthera.2012.09.006. hdl:10261/88634. PMID 23022360.
Olfson M; Marcus SC (2006). "Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study". Archives of General Psychiatry. 63 (8): 865–72. doi:10.1001/archpsyc.63.8.865. PMID 16894062.
Taylor MJ; Rudkin L (2013). "Strategies for managing sexual dysfunction induced by antidepressant medication". The Cochrane Database of Rystematic Reviews. 5 (5): CD003382. doi:10.1002/14651858.CD003382.pub3. PMID 23728643.
Bahrick A 2008 (2008). "Persistence of Sexual Dysfunction Side Effects after Discontinuation of Antidepressant Medications: Emerging Evidence". The Open Psychology Journal. 1: 42–50. doi:10.2174/1874350100801010042.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Kennedy SH; Rizvi S (2009). "Sexual Dysfunction, Depression, and the Impact of Antidepressants". Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977. S2CID 739831.
Weinrieb RM; Auriacombe M (2005). "Selective serotonin re-uptake inhibitors and the risk of bleeding". Expert Opinion on Drug Safety. 4 (2): 337–44. doi:10.1517/14740338.4.2.337. PMID 15794724. S2CID 46551382.
Andrade C; Sandarsh S (2010). "Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–1575. doi:10.4088/JCP.09r05786blu. PMID 21190637.
de Abajo FJ; García-Rodríguez LA (2008). "Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents". Archives of General Psychiatry. 65 (7): 795–803. doi:10.1001/archpsyc.65.7.795. PMID 18606952. S2CID 6822650.
Andrade C; Sandarsh S (2010). "Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–75. doi:10.4088/JCP.09r05786blu. PMID 21190637.
de Abajo FJ (2011). "Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients". Drugs & Aging. 28 (5): 345–67. doi:10.2165/11589340-000000000-00000. PMID 21542658. S2CID 116561324.
Wu Q; Bencaz AF (2012). "Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies". Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 23 (1): 365–75. doi:10.1007/s00198-011-1778-8. PMID 21904950. S2CID 37138272.
Stahl SM; Lonnen AJ (2011). "The Mechanism of Drug-induced Akathsia". CNS Spectrums. 16 (1): 7–10. doi:10.1017/S1092852912000107. PMID 21406165. S2CID 43399486.
Lane RM 1998 (1998). "SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment". Journal of Psychopharmacology (Oxford, England). 12 (2): 192–214. doi:10.1177/026988119801200212. PMID 9694033. S2CID 20944428.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Koliscak LP; Makela EH (2009). "Selective serotonin reuptake inhibitor-induced akathisia". Journal of the American Pharmacists Association : JAPhA. 49 (2): e28–36, quiz e37–8. doi:10.1331/JAPhA.2009.08083. PMID 19289334.
Leo RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". The Journal of Clinical Psychiatry. 57 (10): 449–54. doi:10.4088/JCP.v57n1002. PMID 8909330.
Renoir T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved". Frontiers in Pharmacology. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Borys DJ; Setzer SC (1992). "Acute fluoxetine overdose: a report of 234 cases". The American Journal of Emergency Medicine. 10 (2): 115–20. doi:10.1016/0735-6757(92)90041-U. PMID 1586402.
Oström M; Ericsson A (1996). "Fatal overdose with citalopram". Lancet. 348 (9023): 339–40. doi:10.1016/S0140-6736(05)64513-8. PMID 8709713. S2CID 5287418.
Sporer KA (1995). "The serotonin syndrome. Implicated drugs, pathophysiology and management". Drug Safety : An International Journal of Medical Toxicology and Drug Experience. 13 (2): 94–104. doi:10.2165/00002018-199513020-00004. PMID 7576268. S2CID 19809259.
Isbister GK; Bowe SJ (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". Journal of Toxicology. Clinical Toxicology. 42 (3): 277–85. doi:10.1081/CLT-120037428. PMID 15362595. S2CID 43121327.
Ener RA; Meglathery SB\ (2003). "Serotonin Syndrome and Other Serotonergic Disorders". Pain Medicine. 4 (1): 63–74. doi:10.1046/j.1526-4637.2003.03005.x. PMID 12873279. S2CID 45762494.
Boyer EW; Shannon M (2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–1120. doi:10.1056/NEJMra041867. PMID 15784664. Archived from the original (PDF) on 2013-06-18. Retrieved 2016-02-27.

emedicinehealth.com

Dryden-Edwards, Roxanne (March 31, 2015). "SSRIs and Depression: SSRI Drug Side Effects". EMedicineHealth.com. WebMD, LLC. Retrieved February 27, 2016.

fda.gov

Laughren, Thomas (November 16, 2006). "Results: Estimates of Suicide Risk Associated with Antidepressant Treatment" (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). United States Food and Drug Administration. pp. 33–34. Retrieved February 27, 2016.
Levenson, Mark; Holland, Chris (December 13, 2006). "Antidepressants and Suicidality in Adults: Statistical Evaluation". FDA.gov. United States Food and Drug Association. Retrieved February 27, 2016.
"Revisions to Product Labeling" (PDF). FDA.gov. United States Federal Drug Administration. 2007. Retrieved February 26, 2016.
Hammad TA (August 16, 2004). "Review and evaluation of clinical data. Relationship between psychiatric drugs and pediatric suicidal behavior" (PDF). Overview for December 13 Meeting of Psychopharmacologic Drugs Advisory Committee (PDAC). FDA. pp. 42, 115. Retrieved February 27, 2016.

gov.uk

"Guidance: Selective serotonin reuptake inhibitors (SSRIs) and serotonin and noradrenaline reuptake inhibitors (SNRIs): use and safety". Gov.UK. Medicines and Healthcare products Regulatory Agency of the United Kingdom. December 18, 2014. Retrieved February 27, 2016.

guidelines.gov

"Practice guideline for the treatment of patients with eating disorders". National Guideline Clearinghouse. United States Department of Health and Human Resources. 2011. Archived from the original on May 25, 2013. Retrieved February 27, 2016.

handle.net

hdl.handle.net

Artigas F (2013). "Serotonin Receptors Involved in Antidepressant Effects". Pharmacology and Therapeutics. 137 (1). Elsevier: 119–131. doi:10.1016/j.pharmthera.2012.09.006. hdl:10261/88634. PMID 23022360.

medscape.com

Busko, Marlene (February 28, 2008). "Review Finds SSRIs Modestly Effective in Short-Term Treatment of OCD". Medscape. Archived from the original on April 13, 2013. Retrieved February 26, 2016.

mhra.gov.uk

"Selective Serotonin Reuptake Inhibitors (SSRIs): Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data". Gov.UK. Medicines and Healthcare products Regulatory Agency of the United Kingdom. September 29, 2005. Archived from the original on June 12, 2014. Retrieved February 27, 2016.

nationalarchives.gov.uk

webarchive.nationalarchives.gov.uk

"Selective Serotonin Reuptake Inhibitors (SSRIs): Overview of regulatory status and CSM advice relating to major depressive disorder (MDD) in children and adolescents including a summary of available safety and efficacy data". Gov.UK. Medicines and Healthcare products Regulatory Agency of the United Kingdom. September 29, 2005. Archived from the original on June 12, 2014. Retrieved February 27, 2016.

nice.org.uk

"Depression in Adults: Recognition and Management". National Institute for Health and Care Excellence. RCPsych Publications. 2009.
"Eating Disorders in Over 8s: Management" (PDF). National Institute for Health and Care Excellence. January 2004. Retrieved February 26, 2016.

nih.gov

pubmed.ncbi.nlm.nih.gov

Kapczinski F; Lima MS (2003). Kapczinski, Flavio FK (ed.). "Antidepressants for generalized anxiety disorder". The Cochrane Database of Systematic Reviews (2): CD003592. doi:10.1002/14651858.CD003592. PMID 12804478.
Arroll B; Elley CR (2009). Arroll, Bruce (ed.). "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews. 2014 (3): CD007954. doi:10.1002/14651858.CD007954. PMC 10576545. PMID 19588448.
Hetrick SE; Purcell R (July 7, 2010). "Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)". The Cochrane Database of Systematic Reviews (7): CD007316. doi:10.1002/14651858.CD007316.pub2. PMID 20614457.
Berger W; Mendlowicz MV (2009). "Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33 (2): 169–180. doi:10.1016/j.pnpbp.2008.12.004. ISSN 0278-5846. PMC 2720612. PMID 19141307.
Bandelow B; Zohar J (2008). "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision". The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry. 9 (4): 248–312. doi:10.1080/15622970802465807. ISSN 1562-2975. PMID 18949648. S2CID 39027026.
Hoskins M; Pearce J (2015). "Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis". British Journal of Psychiatry. 206 (2): 93–100. doi:10.1192/bjp.bp.114.148551. PMID 25644881.
Flament MF; Bissada H (2012). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249. S2CID 24864203.
Sansone RA; Sansone LA 2008 (2008). "Pain, Pain, Go Away: Antidepressants and Pain Management". Psychiatry. 5 (12): 16–19. doi:10.4230/LIPIcs.FSTTCS.2015.69. PMC 2729622. PMID 19724772. S2CID 2729622.{{cite journal}}: CS1 maint: numeric names: authors list (link) CS1 maint: unflagged free DOI (link)
Artigas F (2013). "Serotonin Receptors Involved in Antidepressant Effects". Pharmacology and Therapeutics. 137 (1). Elsevier: 119–131. doi:10.1016/j.pharmthera.2012.09.006. hdl:10261/88634. PMID 23022360.
Olfson M; Marcus SC (2006). "Antidepressant drug therapy and suicide in severely depressed children and adults: A case-control study". Archives of General Psychiatry. 63 (8): 865–72. doi:10.1001/archpsyc.63.8.865. PMID 16894062.
Taylor MJ; Rudkin L (2013). "Strategies for managing sexual dysfunction induced by antidepressant medication". The Cochrane Database of Rystematic Reviews. 5 (5): CD003382. doi:10.1002/14651858.CD003382.pub3. PMID 23728643.
Kennedy SH; Rizvi S (2009). "Sexual Dysfunction, Depression, and the Impact of Antidepressants". Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977. S2CID 739831.
Weinrieb RM; Auriacombe M (2005). "Selective serotonin re-uptake inhibitors and the risk of bleeding". Expert Opinion on Drug Safety. 4 (2): 337–44. doi:10.1517/14740338.4.2.337. PMID 15794724. S2CID 46551382.
Andrade C; Sandarsh S (2010). "Serotonin Reuptake Inhibitor Antidepressants and Abnormal Bleeding: A Review for Clinicians and a Reconsideration of Mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–1575. doi:10.4088/JCP.09r05786blu. PMID 21190637.
de Abajo FJ; García-Rodríguez LA (2008). "Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents". Archives of General Psychiatry. 65 (7): 795–803. doi:10.1001/archpsyc.65.7.795. PMID 18606952. S2CID 6822650.
Andrade C; Sandarsh S (2010). "Serotonin reuptake inhibitor antidepressants and abnormal bleeding: a review for clinicians and a reconsideration of mechanisms". The Journal of Clinical Psychiatry. 71 (12): 1565–75. doi:10.4088/JCP.09r05786blu. PMID 21190637.
de Abajo FJ (2011). "Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients". Drugs & Aging. 28 (5): 345–67. doi:10.2165/11589340-000000000-00000. PMID 21542658. S2CID 116561324.
Wu Q; Bencaz AF (2012). "Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies". Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 23 (1): 365–75. doi:10.1007/s00198-011-1778-8. PMID 21904950. S2CID 37138272.
Stahl SM; Lonnen AJ (2011). "The Mechanism of Drug-induced Akathsia". CNS Spectrums. 16 (1): 7–10. doi:10.1017/S1092852912000107. PMID 21406165. S2CID 43399486.
Lane RM 1998 (1998). "SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment". Journal of Psychopharmacology (Oxford, England). 12 (2): 192–214. doi:10.1177/026988119801200212. PMID 9694033. S2CID 20944428.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Koliscak LP; Makela EH (2009). "Selective serotonin reuptake inhibitor-induced akathisia". Journal of the American Pharmacists Association : JAPhA. 49 (2): e28–36, quiz e37–8. doi:10.1331/JAPhA.2009.08083. PMID 19289334.
Leo RJ (1996). "Movement disorders associated with the serotonin selective reuptake inhibitors". The Journal of Clinical Psychiatry. 57 (10): 449–54. doi:10.4088/JCP.v57n1002. PMID 8909330.
Renoir T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved". Frontiers in Pharmacology. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.
Borys DJ; Setzer SC (1992). "Acute fluoxetine overdose: a report of 234 cases". The American Journal of Emergency Medicine. 10 (2): 115–20. doi:10.1016/0735-6757(92)90041-U. PMID 1586402.
Oström M; Ericsson A (1996). "Fatal overdose with citalopram". Lancet. 348 (9023): 339–40. doi:10.1016/S0140-6736(05)64513-8. PMID 8709713. S2CID 5287418.
Sporer KA (1995). "The serotonin syndrome. Implicated drugs, pathophysiology and management". Drug Safety : An International Journal of Medical Toxicology and Drug Experience. 13 (2): 94–104. doi:10.2165/00002018-199513020-00004. PMID 7576268. S2CID 19809259.
Isbister GK; Bowe SJ (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". Journal of Toxicology. Clinical Toxicology. 42 (3): 277–85. doi:10.1081/CLT-120037428. PMID 15362595. S2CID 43121327.
Ener RA; Meglathery SB\ (2003). "Serotonin Syndrome and Other Serotonergic Disorders". Pain Medicine. 4 (1): 63–74. doi:10.1046/j.1526-4637.2003.03005.x. PMID 12873279. S2CID 45762494.
Boyer EW; Shannon M (2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–1120. doi:10.1056/NEJMra041867. PMID 15784664. Archived from the original (PDF) on 2013-06-18. Retrieved 2016-02-27.

ncbi.nlm.nih.gov

Arroll B; Elley CR (2009). Arroll, Bruce (ed.). "Antidepressants versus placebo for depression in primary care". The Cochrane Database of Systematic Reviews. 2014 (3): CD007954. doi:10.1002/14651858.CD007954. PMC 10576545. PMID 19588448.
Berger W; Mendlowicz MV (2009). "Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33 (2): 169–180. doi:10.1016/j.pnpbp.2008.12.004. ISSN 0278-5846. PMC 2720612. PMID 19141307.
Bandelow B; Zohar J (2008). "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision". The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry. 9 (4): 248–312. doi:10.1080/15622970802465807. ISSN 1562-2975. PMID 18949648. S2CID 39027026.
Sansone RA; Sansone LA 2008 (2008). "Pain, Pain, Go Away: Antidepressants and Pain Management". Psychiatry. 5 (12): 16–19. doi:10.4230/LIPIcs.FSTTCS.2015.69. PMC 2729622. PMID 19724772. S2CID 2729622.{{cite journal}}: CS1 maint: numeric names: authors list (link) CS1 maint: unflagged free DOI (link)
Renoir T (2013). "Selective serotonin reuptake inhibitor antidepressant treatment discontinuation syndrome: A review of the clinical evidence and the possible mechanisms involved". Frontiers in Pharmacology. 4: 45. doi:10.3389/fphar.2013.00045. PMC 3627130. PMID 23596418.

psychiatryonline.org

"Practice Guideline for the Treatment of Patients With Major Depressive Disorder" (PDF) (3rd ed.). American Psychiatric Association. pp. 36–39. Retrieved February 27, 2016.

semanticscholar.org

api.semanticscholar.org

Bandelow B; Zohar J (2008). "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision". The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry. 9 (4): 248–312. doi:10.1080/15622970802465807. ISSN 1562-2975. PMID 18949648. S2CID 39027026.
Flament MF; Bissada H (2012). "Evidence-based pharmacotherapy of eating disorders". The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (CINP). 15 (2): 189–207. doi:10.1017/S1461145711000381. PMID 21414249. S2CID 24864203.
Sansone RA; Sansone LA 2008 (2008). "Pain, Pain, Go Away: Antidepressants and Pain Management". Psychiatry. 5 (12): 16–19. doi:10.4230/LIPIcs.FSTTCS.2015.69. PMC 2729622. PMID 19724772. S2CID 2729622.{{cite journal}}: CS1 maint: numeric names: authors list (link) CS1 maint: unflagged free DOI (link)
Kennedy SH; Rizvi S (2009). "Sexual Dysfunction, Depression, and the Impact of Antidepressants". Journal of Clinical Psychopharmacology. 29 (2): 157–64. doi:10.1097/jcp.0b013e31819c76e9. PMID 19512977. S2CID 739831.
Weinrieb RM; Auriacombe M (2005). "Selective serotonin re-uptake inhibitors and the risk of bleeding". Expert Opinion on Drug Safety. 4 (2): 337–44. doi:10.1517/14740338.4.2.337. PMID 15794724. S2CID 46551382.
de Abajo FJ; García-Rodríguez LA (2008). "Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents". Archives of General Psychiatry. 65 (7): 795–803. doi:10.1001/archpsyc.65.7.795. PMID 18606952. S2CID 6822650.
de Abajo FJ (2011). "Effects of selective serotonin reuptake inhibitors on platelet function: mechanisms, clinical outcomes and implications for use in elderly patients". Drugs & Aging. 28 (5): 345–67. doi:10.2165/11589340-000000000-00000. PMID 21542658. S2CID 116561324.
Wu Q; Bencaz AF (2012). "Selective serotonin reuptake inhibitor treatment and risk of fractures: a meta-analysis of cohort and case-control studies". Osteoporosis International : A Journal Established as Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 23 (1): 365–75. doi:10.1007/s00198-011-1778-8. PMID 21904950. S2CID 37138272.
Stahl SM; Lonnen AJ (2011). "The Mechanism of Drug-induced Akathsia". CNS Spectrums. 16 (1): 7–10. doi:10.1017/S1092852912000107. PMID 21406165. S2CID 43399486.
Lane RM 1998 (1998). "SSRI-induced extrapyramidal side-effects and akathisia: implications for treatment". Journal of Psychopharmacology (Oxford, England). 12 (2): 192–214. doi:10.1177/026988119801200212. PMID 9694033. S2CID 20944428.{{cite journal}}: CS1 maint: numeric names: authors list (link)
Oström M; Ericsson A (1996). "Fatal overdose with citalopram". Lancet. 348 (9023): 339–40. doi:10.1016/S0140-6736(05)64513-8. PMID 8709713. S2CID 5287418.
Sporer KA (1995). "The serotonin syndrome. Implicated drugs, pathophysiology and management". Drug Safety : An International Journal of Medical Toxicology and Drug Experience. 13 (2): 94–104. doi:10.2165/00002018-199513020-00004. PMID 7576268. S2CID 19809259.
Isbister GK; Bowe SJ (2004). "Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose". Journal of Toxicology. Clinical Toxicology. 42 (3): 277–85. doi:10.1081/CLT-120037428. PMID 15362595. S2CID 43121327.
Ener RA; Meglathery SB\ (2003). "Serotonin Syndrome and Other Serotonergic Disorders". Pain Medicine. 4 (1): 63–74. doi:10.1046/j.1526-4637.2003.03005.x. PMID 12873279. S2CID 45762494.

ucsd.edu

toxicology.ucsd.edu

Boyer EW; Shannon M (2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–1120. doi:10.1056/NEJMra041867. PMID 15784664. Archived from the original (PDF) on 2013-06-18. Retrieved 2016-02-27.

web.archive.org

Busko, Marlene (February 28, 2008). "Review Finds SSRIs Modestly Effective in Short-Term Treatment of OCD". Medscape. Archived from the original on April 13, 2013. Retrieved February 26, 2016.
"Practice guideline for the treatment of patients with eating disorders". National Guideline Clearinghouse. United States Department of Health and Human Resources. 2011. Archived from the original on May 25, 2013. Retrieved February 27, 2016.
Boyer EW; Shannon M (2005). "The serotonin syndrome" (PDF). The New England Journal of Medicine. 352 (11): 1112–1120. doi:10.1056/NEJMra041867. PMID 15784664. Archived from the original (PDF) on 2013-06-18. Retrieved 2016-02-27.

worldcat.org

search.worldcat.org

Berger W; Mendlowicz MV (2009). "Pharmacologic alternatives to antidepressants in posttraumatic stress disorder: A systematic review". Progress in Neuro-Psychopharmacology & Biological Psychiatry. 33 (2): 169–180. doi:10.1016/j.pnpbp.2008.12.004. ISSN 0278-5846. PMC 2720612. PMID 19141307.
Bandelow B; Zohar J (2008). "World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision". The World Journal of Biological Psychiatry: The Official Journal of the World Federation of Societies of Biological Psychiatry. 9 (4): 248–312. doi:10.1080/15622970802465807. ISSN 1562-2975. PMID 18949648. S2CID 39027026.